ACCPL latest shareholding pattern: promoter holding, FII / FPI holding, DII and mutual fund holding, public holding and number of shareholders, quarter by quarter.
As of Sep 2026, promoters held 73.52% of Accretion Pharmaceuticals Ltd, FIIs 0.17%, DIIs 3.65%, government - and the public 22.66%, across 719 shareholders.